02.05.2013 Views

Muehlhan AG Buy

Muehlhan AG Buy

Muehlhan AG Buy

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Muehlhan</strong> <strong>AG</strong><br />

(CDAX, Industrial Goods & Services)<br />

<strong>Buy</strong><br />

EUR 2.00<br />

Price EUR 1.05<br />

Upside 90.1 %<br />

Frank Laser<br />

flaser@warburg-research.com<br />

+49 (0)40-309537-235<br />

Value Indicators: EUR Share data: Description:<br />

DCF: 2.07<br />

FCF-Value Potential: 2.34<br />

Bloomberg: M4N GR<br />

Reuters: M4NG<br />

ISIN: DE000A0KD0F7<br />

C O M M E N T Published 31.07.2012 1<br />

Service company for corrosion<br />

protection at ships, offshore and<br />

production plants<br />

Market Snapshot: EUR m Shareholders: Risk Profile (WRe): 2012e<br />

Market cap: 1<br />

No. of shares (m): 20<br />

EV: 12<br />

Freefloat MC (ord.): 0<br />

Ø Trad. Vol. (ord./30d): 7.72 th<br />

Freefloat 34.2 %<br />

GIVE 23.9 %<br />

Syntegra 21.1 %<br />

GIMS 13.2 %<br />

Q2 figures in line with estimates; Full year guidance confirmed.<br />

Figures Q2/2012: Comment on Figures:<br />

FY End: 31.12.<br />

in EUR m<br />

Q2<br />

2012<br />

Q2<br />

2012e<br />

Q2<br />

2011 yoy<br />

6M<br />

2012<br />

6M<br />

2012e<br />

6M<br />

2011 yoy<br />

Beta: 1.5<br />

Price / Book: 0.0<br />

Net Gearing: 21 %<br />

Debt / Equity: 104 %<br />

Net debt / EBITDA: 1.0 x<br />

Sales increase mainly triggered by satisfactory demand in Europe and<br />

Asia Pacific<br />

Ship Repair, Energy and Industry could more than compensate for the<br />

(expected) sales decrease in Ship newbuilding<br />

EBIT slightly below last year’s level due to the internationalisation of the<br />

wind-energy business and corresponding start-up losses in Canada<br />

(implementation of a new subsidiary)<br />

Sales 47 45 41 13.7 % 90 88 81 11.4 %<br />

EBIT 2 2 2 -10.1 % 2 2 2 -22.9<br />

Margin 4.2 % 4.4 % 5.3 % 2.0 % 2.3 % 2.9 % %<br />

Net income 1 1 1 14.8 % 0 0 1 -74.0<br />

Margin 1.9 % 2.2 % 1.9 % 0.2 % 0.4 % 0.6 % %<br />

EPS 0.05 0.04 0.04 25.0 % 0.01 0.01 0.03 -66.7<br />

%<br />

Monday, <strong>Muehlhan</strong> reported Q2 2012 figures which were in line with expectations, showed notable improvement on the weak first three months<br />

of the year and supported visibility on the company’s full year guidance.<br />

Sales soared by almost 14%, to which all business units – except the Ship Newbuilding segment - contributed. The latter was again negatively<br />

influenced by structural changes in the market for new ships and saw a 13% sales decline in the second quarter. In contrast Ship Repair (Q2<br />

sales: +25%), Energy (+30%) and Other Services (+33%) generated double-digit growth rates in Q2. Ship Repair was triggered by major<br />

projects in the offshore business as well as heavy-loaded vessels and drillships.<br />

Continuing high demand from the petrochemical industry led to healthy growth rates in the Energy segment. Structural engineering projects<br />

and strong demand for complex steel foundations for offshore wind turbines boosted sales in Other Services.<br />

Nevertheless, the strong sales volume growth did not fully feed through to the p/l as the operating business (Q2 EBIT: EUR -1.3m vs.<br />

EUR 2.17m in Q2 2011) was negatively impacted by ramp-up costs in Canada for a new subsidiary of <strong>Muehlhan</strong>’s wind energy business.<br />

Furthermore, the North American region had to cope with problems at a shipbuilding subsidiary on the Gulf Coast. In contrast, EBIT in Europe<br />

increased by more than 50%, spurred by strong growth in the steel construction business, high demand at scaffolding and the recovery of the<br />

repair segment.<br />

Although operating in cyclical industries, the figures provide first evidence of the company’s successful restructuring and focussing efforts. As a<br />

consequence, <strong>Muehlhan</strong> reiterated its FY 2012 guidance, aiming for sales of EUR 165-175m and EBIT in the range of EUR 3-5m.<br />

Given Q2 figures and despite a rather gloomy macroeconomic picture, the recent drop in share price does not really seem justified. This comes<br />

together with a healthy balance sheet (e.g. equity ratio north of 50%) and a high management quality. The <strong>Buy</strong> rating is reiterated.<br />

Rel. Performance vs CDAX:<br />

1 month: -8.6 %<br />

6 months: -27.3 %<br />

Year to date: -28.9 %<br />

Trailing 12 months: -39.2 %<br />

Company events:<br />

11/15/12 Q3<br />

FY End: 31.12.<br />

in EUR m<br />

C<strong>AG</strong>R<br />

(11-14e) 2008 2009 2010 2011 2012e 2013e 2014e<br />

Sales 0.8 % 207 191 165 172 170 172 176<br />

Change Sales yoy 5.3 % -7.6 % -13.5 % 4.4 % -1.6 % 1.5 % 2.5 %<br />

Gross profit margin 54.9 % 52.7 % 56.7 % 58.1 % 59.0 % 60.0 % 60.0 %<br />

EBITDA 33.5 % 17 15 7 6 11 13 15<br />

Margin 8.2 % 8.0 % 4.2 % 3.7 % 6.4 % 7.7 % 8.7 %<br />

EBIT - 10 8 -2 -1 4 6 8<br />

Margin 4.8 % 4.4 % -1.5 % -0.8 % 2.3 % 3.5 % 4.6 %<br />

Net income - 4 4 -4 -4 1 3 4<br />

EPS - 0.22 0.20 -0.23 -0.21 0.06 0.13 0.20<br />

EPS adj. - 0.22 0.20 -0.23 -0.21 0.06 0.13 0.20<br />

DPS - 0.00 0.06 0.00 0.00 0.00 0.05 0.08<br />

Dividend Yield 0.0 % 3.1 % 0.0 % 0.0 % 0.0 % 4.8 % 7.7 %<br />

FCFPS 0.32 0.34 -0.22 -0.17 0.14 0.22 0.18<br />

EV / Sales 0.4 x 0.2 x 0.4 x 0.3 x 0.1 x 0.0 x 0.0 x<br />

EV / EBITDA 4.8 x 3.0 x 8.7 x 7.0 x 1.1 x 0.6 x 0.3 x<br />

EV / EBIT 8.3 x 5.5 x -24.6 x -34.3 x 3.0 x 1.3 x 0.6 x<br />

P / E 12.4 x 9.6 x -11.5 x -7.9 x 17.5 x 8.1 x 5.2 x<br />

P / E adj. 12.4 x 9.6 x -11.5 x -7.9 x 17.5 x 8.1 x 5.2 x<br />

FCF Yield Potential 10.4 % 17.5 % 2.9 % 2.3 % 47.0 % 94.7 % 168.9 %<br />

Net Debt 29 9 11 13 11 6 4<br />

ROE 7.3 % 6.1 % -7.0 % -6.7 % 2.3 % 5.0 % 7.2 %<br />

ROCE 6.6 % 6.0 % -3.3 % -1.8 % 3.3 % 5.1 % 6.7 %<br />

Guidance: 2012: Sales EUR 165-175m; EBIT EUR 3-5m


<strong>Muehlhan</strong> <strong>AG</strong><br />

Sales development<br />

in EUR m<br />

Source: Warburg Research<br />

Company Background<br />

Sales by regions<br />

2011; in %<br />

Source: Warburg Research<br />

C O M M E N T Published 31.07.2012 2<br />

EBIT development<br />

in EUR m<br />

Source: Warburg Research<br />

<strong>Muehlhan</strong> is one of the leading providers of specialized services in connection with corrosion protection of surfaces, particularly for<br />

ships, infrastructural facilities like bridges, drilling rigs + wind generators.<br />

The coating is applied on newly built objects first and is renewed in regular maintenance intervals of 5-10 years.<br />

Ship Newbuilding and Ship Repair are the company's important pillars. As a result of the diversification of the business activities,<br />

however, the Industry Services segment has the highest sales contribution by now.<br />

This is partly due to the regional diversification for which the Middle East is playing an increasingly important role and where<br />

<strong>Muehlhan</strong> solely provides industry services.<br />

Competitive Quality<br />

The competitive quality vis-à-vis a high number of mainly smaller competitors is a result of...<br />

...the comparably strong financing power, the long-standing customer relationships as well as the brand name resulting from quality<br />

and tradition.<br />

The capital intensity of larger and more complex orders limits the ROCE to some extent but it also creates barriers to market entry for<br />

smaller competitors.<br />

Although the shipping segments should continue to be challenging <strong>Muehlhan</strong> is likely to benefit from the expected market<br />

consolidation as less diversified and financially weaker competitors will withdraw from the market.<br />

EBT development<br />

in EUR m<br />

Source: Warburg Research<br />

Sales by segments<br />

2011; in %<br />

Source: Warburg Research<br />

Net income development<br />

in EUR m<br />

Source: Warburg Research


<strong>Muehlhan</strong> <strong>AG</strong><br />

DCF model<br />

Detailed forecast period Transitional period Term. Value<br />

Figures in EUR m 2012e 2013e 2014e 2015e 2016e 2017e 2018e 2019e 2020e 2021e 2022e 2023e 2024e<br />

Sales 170 172 176 181 185 190 195 199 203 208 212 216 220<br />

Sales change -1.6 % 1.5 % 2.5 % 2.5 % 2.5 % 2.5 % 2.5 % 2.5 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 %<br />

EBIT 4 6 8 7 7 7 7 7 7 7 7 8 8<br />

EBIT-margin 2.3 % 3.5 % 4.6 % 4.0 % 4.0 % 3.5 % 3.5 % 3.5 % 3.5 % 3.5 % 3.5 % 3.5 % 3.5 %<br />

Tax rate (EBT) 34.0 % 34.0 % 34.0 % 34.0 % 34.0 % 35.0 % 35.0 % 35.0 % 35.0 % 35.0 % 35.0 % 35.0 % 35.0 %<br />

NOPAT 3 4 5 5 5 4 4 5 5 5 5 5 5<br />

Depreciation 7 7 7 6 6 6 7 7 7 7 7 7 7<br />

in % of Sales 4.1 % 4.2 % 4.1 % 3.4 % 3.4 % 3.4 % 3.4 % 3.4 % 3.4 % 3.4 % 3.4 % 3.4 % 3.4 %<br />

Changes in provisions 0 0 0 0 0 0 0 0 0 0 0 0 0<br />

Change in Liquidity from<br />

- Working Capital -7 -1 1 1 2 2 1 1 1 2 1 1 1<br />

- Capex 6 6 7 6 6 7 7 7 7 7 7 7 7<br />

Capex in % of Sales 3.8 % 3.8 % 3.8 % 3.5 % 3.5 % 3.5 % 3.5 % 3.5 % 3.5 % 3.4 % 3.4 % 3.4 % 3.4 %<br />

Other 0 0 0 0 0 0 0 0 0 0 0 0 0<br />

Free Cash Flow (WACC<br />

Model)<br />

10 6 5 3 3 3 4 4 4 3 4 4 4 4<br />

PV of FCF 10 5 4 2 2 2 2 2 2 1 2 1 1 18<br />

share of PVs 34.51 % 31.92 % 33.57 %<br />

Model parameter Valuation (m)<br />

Derivation of WACC: Derivation of Beta: Present values 2024e 36<br />

Terminal Value 18<br />

Debt ratio 25.00 % Financial Strength 1.50 Financial liabilities 23<br />

Cost of debt 4.6 % Liquidity 1.50 Pension liabilities 1<br />

Market return 9.00 % Cyclicality 1.50 Hybrid capital 0<br />

Risk free rate 4.00 % Transparency 1.50 Minority interest 0<br />

Others 1.50 Market val. of investments 0<br />

Liquidity 11 No. of shares (m) 19.5<br />

WACC 9.76 % Beta 1.50 Equity Value 40 Value per share (EUR) 2.07<br />

Sensitivity Value per Share (EUR)<br />

Terminal Growth Delta EBIT-margin<br />

Beta (WACC) 1.25 % 1.50 % 1.75 % 2.00 % 2.25 % 2.50 % 2.75 % Beta (WACC) -1.5 pp -1.0 pp -0.5 pp 0.0 +0.5 pp +1.0 pp +1.5 pp<br />

1.77 (10.8 %) 1.75 1.77 1.79 1.81 1.83 1.85 1.88 1.77 (10.8 %) 0.76 1.11 1.46 1.81 2.16 2.51 2.85<br />

1.63 (10.3 %) 1.86 1.88 1.90 1.93 1.95 1.98 2.01 1.63 (10.3 %) 0.82 1.19 1.56 1.93 2.30 2.67 3.04<br />

1.57 (10.0 %) 1.92 1.94 1.97 2.00 2.02 2.05 2.09 1.57 (10.0 %) 0.85 1.23 1.62 2.00 2.38 2.76 3.14<br />

1.50 (9.8 %) 1.99 2.01 2.04 2.07 2.10 2.13 2.17 1.50 (9.8 %) 0.89 1.28 1.67 2.07 2.46 2.85 3.24<br />

1.43 (9.5 %) 2.05 2.08 2.11 2.14 2.18 2.21 2.25 1.43 (9.5 %) 0.93 1.33 1.74 2.14 2.55 2.95 3.36<br />

1.37 (9.3 %) 2.13 2.16 2.19 2.22 2.26 2.30 2.35 1.37 (9.3 %) 0.97 1.39 1.81 2.22 2.64 3.06 3.48<br />

1.23 (8.8 %) 2.29 2.32 2.36 2.41 2.45 2.50 2.55 1.23 (8.8 %) 1.06 1.51 1.96 2.41 2.85 3.30 3.75<br />

High beta due to low visibility and high cyclicality<br />

Long term growth rates in line with market growth<br />

C O M M E N T Published 31.07.2012 3


<strong>Muehlhan</strong> <strong>AG</strong><br />

Free Cash Flow Value Potential<br />

Warburg Research's valuation tool "FCF Value Potential" reflects the ability of the company to generate sustainable free cash flows. It is based on the<br />

"FCF potential" - a FCF "ex growth" figure - which assumes unchanged working capital and pure maintenance capex. A value indication is derived by<br />

discounting the “FCF potential” of a given year with the weighted costs of capital. The fluctuating value indications over time add a timing element to the<br />

DCF model (our preferred valuation tool).<br />

in EUR m 2008 2009 2010 2011 2012e 2013e 2014e<br />

Net Income before minorities 5 4 -4 -4 1 3 4<br />

+ Depreciation + Amortisation 7 7 9 8 7 7 7<br />

- Net Interest Income -2 -2 -1 -2 -2 -2 -2<br />

- Maintenance Capex 6 5 5 5 5 5 5<br />

+ Others 0 0 0 0 0 0 0<br />

= Free Cash Flow Potential 9 8 2 1 5 7 8<br />

Free Cash Flow Yield Potential 10.4 % 17.5 % 2.9 % 2.3 % 47.0 % 94.7 % 168.9 %<br />

WACC 9.76 % 9.76 % 9.76 % 9.76 % 9.76 % 9.76 % 9.76 %<br />

= Enterprise Value (EV) 82 46 61 45 12 7 5<br />

= Fair Enterprise Value 87 83 18 11 56 72 86<br />

- Net Debt (Cash) 12 12 12 12 10 6 3<br />

- Pension Liabilities 1 1 1 1 1 1 1<br />

- Others 0 0 0 0 0 0 0<br />

- Market value of minorities 0 0 0 0 0 0 0<br />

+ Market value of investments 0 0 0 0 0 0 0<br />

= Fair Market Capitalisation 74 69 5 n.a. 46 66 82<br />

No. of shares (total) (m) 20 20 20 20 20 20 20<br />

= Fair value per share (EUR) 3.80 3.56 0.26 n.a. 2.34 3.38 4.20<br />

premium (-) / discount (+) in % 122.5 % 221.7 % 304.8 %<br />

Sensitivity Fair value per Share (EUR)<br />

12.76 % 2.75 2.56 0.04 n.a. 1.66 2.51 3.16<br />

11.76 % 3.04 2.84 0.10 n.a. 1.85 2.75 3.45<br />

10.76 % 3.38 3.16 0.17 n.a. 2.07 3.04 3.79<br />

WACC 9.76 % 3.80 3.56 0.26 n.a. 2.34 3.38 4.20<br />

8.76 % 4.31 4.04 0.37 n.a. 2.67 3.81 4.70<br />

7.76 % 4.95 4.65 0.50 0.00 3.08 4.34 5.33<br />

6.76 % 5.78 5.44 0.68 0.10 3.62 5.03 6.15<br />

Cash flows about to stabilise due to restructuring and new focus<br />

Long term potential significantly above current share price<br />

C O M M E N T Published 31.07.2012 4


<strong>Muehlhan</strong> <strong>AG</strong><br />

Valuation<br />

2008 2009 2010 2011 2012e 2013e 2014e<br />

Price / Book 0.8 x 0.6 x 0.8 x 0.6 x 0.0 x 0.0 x 0.0 x<br />

Book value per share ex intangibles 1.82 2.01 2.01 1.86 1.49 1.63 1.77<br />

EV / Sales 0.4 x 0.2 x 0.4 x 0.3 x 0.1 x 0.0 x 0.0 x<br />

EV / EBITDA 4.8 x 3.0 x 8.7 x 7.0 x 1.1 x 0.6 x 0.3 x<br />

EV / EBIT 8.3 x 5.5 x -24.6 x -34.3 x 3.0 x 1.3 x 0.6 x<br />

EV / EBIT adj.* 8.3 x 5.5 x -24.6 x -34.3 x 3.0 x 1.3 x 0.6 x<br />

P / FCF 8.6 x 5.6 x -12.3 x -9.9 x 7.6 x 4.8 x 5.6 x<br />

P / E 12.4 x 9.6 x -11.5 x -7.9 x 17.5 x 8.1 x 5.2 x<br />

P / E adj.* 12.4 x 9.6 x -11.5 x -7.9 x 17.5 x 8.1 x 5.2 x<br />

Dividend Yield 0.0 % 3.1 % 0.0 % 0.0 % 0.0 % 4.8 % 7.7 %<br />

Free Cash Flow Yield Potential 10.4 % 17.5 % 2.9 % 2.3 % 47.0 % 94.7 % 168.9 %<br />

*Adjustments made for: -<br />

C O M M E N T Published 31.07.2012 5


<strong>Muehlhan</strong> <strong>AG</strong><br />

Consolidated profit & loss<br />

In EUR m 2008 2009 2010 2011 2012e 2013e 2014e<br />

Sales 207 191 165 172 170 172 176<br />

Change Sales yoy 5.3 % -7.6 % -13.5 % 4.4 % -1.6 % 1.5 % 2.5 %<br />

Increase / decrease in inventory 0 0 0 0 0 0 0<br />

Own work capitalised 0 0 0 0 0 0 0<br />

Total Sales 207 191 165 172 170 172 176<br />

Material Expenses 93 90 71 72 69 69 71<br />

Gross profit 113 101 94 100 100 103 106<br />

Gross profit margin 54.9 % 52.7 % 56.7 % 58.1 % 59.0 % 60.0 % 60.0 %<br />

Personnel expenses 71 63 62 66 64 64 65<br />

Other operating income 7 6 5 4 4 4 4<br />

Other operating expenses 32 29 29 31 29 30 30<br />

Unfrequent items 0 0 0 0 0 0 0<br />

EBITDA 17 15 7 6 11 13 15<br />

Margin 8.2 % 8.0 % 4.2 % 3.7 % 6.4 % 7.7 % 8.7 %<br />

Depreciation of fixed assets 7 7 6 8 7 7 7<br />

EBITA 10 8 1 -1 4 6 8<br />

Amortisation of intangible assets 0 0 3 0 0 0 0<br />

Goodwill amortization 0 0 0 0 0 0 0<br />

EBIT 10 8 -2 -1 4 6 8<br />

Margin 4.8 % 4.4 % -1.5 % -0.8 % 2.3 % 3.5 % 4.6 %<br />

EBIT adj. 10 8 -2 -1 4 6 8<br />

Interest income 0 1 0 0 0 0 0<br />

Interest expenses 3 2 2 2 2 2 2<br />

Other financial income (loss) 0 0 0 0 0 0 0<br />

EBT 8 7 -4 -3 2 4 6<br />

Margin 3.7 % 3.4 % -2.4 % -2.0 % 1.1 % 2.2 % 3.3 %<br />

Total taxes 3 2 1 1 1 1 2<br />

Net income from continuing operations 5 4 -4 -4 1 3 4<br />

Income from discontinued operations (net of tax) 0 0 0 0 0 0 0<br />

Net income before minorities 5 4 -4 -4 1 3 4<br />

Minority interest -1 -1 0 0 0 0 0<br />

Net income 4 4 -4 -4 1 3 4<br />

Margin 2.1 % 2.0 % -2.6 % -2.3 % 0.7 % 1.5 % 2.2 %<br />

Number of shares, average 20 19 19 19 19 19 19<br />

EPS 0.22 0.20 -0.23 -0.21 0.06 0.13 0.20<br />

EPS adj. 0.22 0.20 -0.23 -0.21 0.06 0.13 0.20<br />

*Adjustments made for:<br />

Guidance: 2012: Sales EUR 165-175m; EBIT EUR 3-5m<br />

Financial Ratios<br />

2008 2009 2010 2011 2012e 2013e 2014e<br />

Total Operating Costs / Sales 91.8 % 92.0 % 95.8 % 96.3 % 93.6 % 92.3 % 91.3 %<br />

Operating Leverage 46.3 x 2.0 x n.a. -10.7 x n.a. 35.0 x 14.1 x<br />

EBITDA / Interest expenses 6.8 x 6.4 x 4.1 x 3.0 x 4.9 x 5.7 x 6.4 x<br />

Tax rate (EBT) 34.1 % 33.0 % -15.3 % -17.0 % 34.0 % 34.0 % 34.0 %<br />

Dividend Payout Ratio 0.0 % 26.7 % 0.0 % 0.0 % 0.0 % 38.0 % 39.8 %<br />

Sales per Employee 83,674 83,180 66,002 68,910 67,800 68,800 70,520<br />

Sales, EBITDA<br />

in EUR m<br />

Source: Warburg Research<br />

Operating Performance<br />

in %<br />

Source: Warburg Research<br />

C O M M E N T Published 31.07.2012 6<br />

Performance per Share<br />

Source: Warburg Research


<strong>Muehlhan</strong> <strong>AG</strong><br />

Consolidated balance sheet<br />

In EUR m 2008 2009 2010 2011 2012e 2013e 2014e<br />

Assets<br />

Goodwill and other intangible assets 25 26 23 21 21 21 21<br />

thereof other intangible assets 1 1 1 1 0 0 0<br />

thereof Goodwill 25 25 22 21 21 21 21<br />

Property, plant and equipment 30 28 23 23 23 22 22<br />

Financial assets 10 0 0 0 0 0 0<br />

Other long-term assets 0 0 0 0 0 0 0<br />

Fixed assets 65 54 46 45 44 43 42<br />

Inventories 4 4 4 4 3 3 4<br />

Accounts receivable 40 36 37 43 35 35 36<br />

Liquid assets 8 12 12 11 13 18 20<br />

Other short-term assets 14 10 9 10 10 10 10<br />

Current assets 66 61 62 67 61 66 69<br />

Total Assets 131 116 108 112 105 109 111<br />

Liabilities and shareholders' equity<br />

Subscribed capital 20 20 20 20 20 20 20<br />

Capital reserve 28 28 28 28 28 28 28<br />

Retained earnings 4 4 10 9 0 1 3<br />

Other equity components 10 14 4 0 1 3 4<br />

Shareholder's equity 61 65 61 57 49 52 54<br />

Minority interest 2 2 0 0 3 3 3<br />

Total equity 63 66 61 57 52 54 57<br />

Provisions 2 1 2 2 2 2 2<br />

thereof provisions for pensions and similar obligations 1 1 1 1 1 1 1<br />

Financial liabilites (total) 36 21 22 23 23 23 23<br />

thereof short-term financial liabilities 1 1 1 1 1 1 1<br />

Accounts payable 17 13 12 17 15 16 16<br />

Other liabilities 14 14 12 14 14 14 14<br />

Liabilities 68 49 47 55 53 54 54<br />

Total liabilities and shareholders' equity 131 116 108 112 105 109 111<br />

Financial Ratios<br />

2008 2009 2010 2011 2012e 2013e 2014e<br />

Efficiency of Capital Employment<br />

Operating Assets Turnover 3.6 x 3.5 x 3.1 x 3.2 x 3.7 x 3.9 x 3.9 x<br />

Capital Employed Turnover 2.1 x 2.2 x 2.0 x 2.1 x 2.2 x 2.2 x 2.2 x<br />

ROA 6.6 % 7.1 % -9.5 % -8.7 % 2.8 % 5.8 % 9.0 %<br />

Return on Capital<br />

ROCE 6.6 % 6.0 % -3.3 % -1.8 % 3.3 % 5.1 % 6.7 %<br />

ROE 7.3 % 6.1 % -7.0 % -6.7 % 2.3 % 5.0 % 7.2 %<br />

Adj. ROE 7.3 % 6.1 % -7.0 % -6.7 % 2.3 % 5.0 % 7.2 %<br />

Balance sheet quality<br />

Net Debt 29 9 11 13 11 6 4<br />

Net Financial Debt 28 8 10 12 10 6 3<br />

Net Gearing 45.7 % 13.7 % 17.5 % 23.2 % 20.6 % 11.8 % 6.9 %<br />

Net Financial Debt / EBITDA 165.8 % 54.7 % 143.0 % 193.3 % 90.1 % 42.4 % 19.8 %<br />

Book Value / Share 3.1 3.3 3.2 3.0 2.6 2.7 2.9<br />

Book value per share ex intangibles 1.8 2.0 2.0 1.9 1.5 1.6 1.8<br />

ROCE Development<br />

Source: Warburg Research<br />

Net debt<br />

in EUR m<br />

Source: Warburg Research<br />

C O M M E N T Published 31.07.2012 7<br />

Book Value per Share<br />

in EUR<br />

Source: Warburg Research


<strong>Muehlhan</strong> <strong>AG</strong><br />

Consolidated cash flow statement<br />

In EUR m 2008 2009 2010 2011 2012e 2013e 2014e<br />

Net income 5 4 -4 -4 1 3 4<br />

Depreciation of fixed assets 7 7 6 8 7 7 7<br />

Amortisation of goodwill 0 0 0 0 0 0 0<br />

Amortisation of intangible assets 0 0 3 0 0 0 0<br />

Increase/decrease in long-term provisions 0 0 0 0 0 0 0<br />

Other non-cash income and expenses -1 2 0 0 -3 0 0<br />

Cash Flow 11 13 5 4 5 10 11<br />

Increase / decrease in inventory 0 0 0 -1 1 0 0<br />

Increase / decrease in accounts receivable 1 3 -2 -5 8 0 -1<br />

Increase / decrease in accounts payable 2 -3 -2 5 -2 1 0<br />

Increase / decrease in other working capital positions 0 0 -1 1 -3 0 0<br />

Increase / decrease in working capital 4 0 -4 0 4 1 -1<br />

Net cash provided by operating activities 15 13 1 4 9 11 10<br />

Investments in intangible assets 0 -1 0 0 0 0 0<br />

Investments in property, plant and equipment -9 -6 -5 -7 -6 -6 -7<br />

Payments for acquisitions -2 0 0 0 0 0 0<br />

Financial investments -10 0 0 0 0 0 0<br />

Income from asset disposals 12 10 5 1 0 0 0<br />

Net cash provided by investing activities -8 4 1 -6 -6 -6 -7<br />

Change in financial liabilities -1 0 1 1 0 0 0<br />

Dividends paid 0 0 -1 0 0 0 -1<br />

Purchase of own shares 0 -1 -1 0 0 0 0<br />

Capital measures 0 -15 0 0 0 0 0<br />

Others -5 4 -1 0 0 0 0<br />

Net cash provided by financing activities -6 -12 -2 1 0 0 -1<br />

Change in liquid funds 1 5 -1 -1 2 4 2<br />

Effects of exchange-rate changes on cash 0 0 1 0 0 0 0<br />

Cash and cash equivalent at end of period 8 12 12 11 13 18 20<br />

Financial Ratios<br />

2008 2009 2010 2011 2012e 2013e 2014e<br />

Cash Flow<br />

Free Cash Flow 6 7 -4 -3 3 4 4<br />

Free Cash Flow / Sales 3.0 % 3.5 % -2.5 % -1.8 % 1.5 % 2.4 % 2.0 %<br />

Free Cash Flow Potential 9 8 2 1 5 7 8<br />

Free Cash Flow / Sales 3.0 % 3.5 % -2.5 % -1.8 % 1.5 % 2.4 % 2.0 %<br />

Free Cash Flow / Net Profit 142.5 % 171.4 % 93.9 % 81.1 % 213.6 % 168.4 % 92.0 %<br />

Interest Received / Avg. Cash 3.1 % 5.1 % 2.5 % 0.6 % 1.2 % 0.9 % 0.8 %<br />

Interest Paid / Avg. Debt 6.9 % 8.4 % 8.0 % 9.3 % 9.5 % 9.9 % 10.5 %<br />

Management of Funds<br />

Investment ratio 4.2 % 3.3 % 3.0 % 4.0 % 3.8 % 3.8 % 3.8 %<br />

Maint. Capex / Sales 2.8 % 2.8 % 2.8 % 2.8 % 2.8 % 2.8 % 2.8 %<br />

Capex / Dep 123.3 % 91.6 % 52.3 % 89.3 % 91.7 % 89.5 % 91.6 %<br />

Avg. Working Capital / Sales 12.4 % 13.9 % 16.8 % 17.3 % 15.8 % 13.3 % 12.9 %<br />

Trade Debtors / Trade Creditors 232.3 % 270.4 % 321.8 % 256.2 % 232.2 % 217.9 % 223.4 %<br />

Inventory Turnover 20.9 x 24.0 x 19.5 x 17.2 x 20.1 x 20.0 x 20.0 x<br />

Receivables collection period (days) 70 68 83 90 75 74 74<br />

Payables payment period (days) 67 53 59 84 79 85 83<br />

Cash conversion cycle (Days) -46 -35 -36 -58 -57 -63 -61<br />

CAPEX and Cash Flow<br />

in EUR m<br />

Source: Warburg Research<br />

Free Cash Flow Generation<br />

Source: Warburg Research<br />

C O M M E N T Published 31.07.2012 8<br />

Working Capital<br />

Source: Warburg Research


<strong>Muehlhan</strong> <strong>AG</strong><br />

LEGAL DISCLAIMER<br />

This research report was prepared by the Warburg Research GmbH, a subsidiary of the M.M.Warburg & CO KGaA and is passed on<br />

by the M.M.Warburg & CO KGaA. It contains selected information and does not purport to be complete. The report is based on<br />

publicly available information and data ("the information") believed to be accurate and complete. Warburg Research GmbH neither<br />

does examine the information to be accurate and complete, nor guarantees its accuracy and completeness. Possible errors or<br />

incompleteness of the information do not constitute grounds for liability of M.M.Warburg & CO KGaA or Warburg Research GmbH for<br />

damages of any kind whatsoever, and M.M.Warburg & CO KGaA and Warburg Research GmbH are not liable for indirect and/or direct<br />

and/or consequential damages. In particular, neither M.M.Warburg & CO KGaA nor Warburg Research GmbH are liable for the<br />

statements, plans or other details contained in these analyses concerning the examined companies, their affiliated companies,<br />

strategies, economic situations, market and competitive situations, regulatory environment, etc. Although due care has been taken in<br />

compiling this research report, it cannot be excluded that it is incomplete or contains errors. M.M.Warburg & CO KGaA and Warburg<br />

Research GmbH, their shareholders and employees are not liable for the accuracy and completeness of the statements, estimations<br />

and the conclusions derived from the information contained in this document. Provided a research report is being transmitted in<br />

connection with an existing contractual relationship, i.e. financial advisory or similar services, the liability of M.M.Warburg & CO KGaA<br />

and Warburg Research GmbH shall be restricted to gross negligence and wilful misconduct. In case of failure in essential tasks,<br />

M.M.Warburg & CO KGaA and Warburg Research GmbH are liable for normal negligence. In any case, the liability of M.M.Warburg &<br />

CO KGaA and Warburg Research GmbH is limited to typical, expectable damages. This research report does not constitute an offer or<br />

a solicitation of an offer for the purchase or sale of any security. Partners, directors or employees of M.M.Warburg & CO KGaA,<br />

Warburg Research GmbH or affiliated companies may serve in a position of responsibility, i.e. on the board of directors of companies<br />

mentioned in the report. Opinions expressed in this report are subject to change without notice. All rights reserved.<br />

COPYRIGHT NOTICE<br />

This work including all its parts is protected by copyright. Any use beyond the limits provided by copyright law without permission is<br />

prohibited and punishable. This applies, in particular, to reproductions, translations, microfilming, and storage and processing on<br />

electronic media of the entire content or parts thereof.<br />

DISCLOSURE ACCORDING TO § 34B OF THE GERMAN SECURITIES TRADING ACT AND FINANV<br />

The valuation underlying the rating of the company analysed in this report is based on generally accepted and widely used methods of<br />

fundamental valuation, such as the DCF model, Free Cash Flow Value Potential, peer group comparison and – where applicable – a<br />

sum-of-the-parts model.<br />

M.M.Warburg & CO KGaA and Warburg Research GmbH have set up internal organisational and administrative arrangements to<br />

prevent and avoid possible conflicts of interest and, where applicable, to disclose them.<br />

Valuations, ratings and price targets for the companies analysed by Warburg Research GmbH are subject to constant reviews and<br />

may therefore change, if any of the fundamental factors underlying these items do change.<br />

All share prices given in this equity analysis are closing prices on the date given in the analysis, except where stated otherwise.<br />

Neither Warburg Research GmbH’s analysts nor M.M.Warburg & CO KGaA’s analysts do receive any payments directly or indirectly<br />

from any investment banking activity of M.M.Warburg Bank or an affiliated company.<br />

M.M.Warburg & CO KGaA and Warburg Research GmbH are under supervision of the BaFin – German Federal Financial Supervisory<br />

Authority.<br />

SOURCES<br />

All data and consensus estimates have been obtained from FactSet except where stated otherwise.<br />

C O M M E N T Published 31.07.2012 9


<strong>Muehlhan</strong> <strong>AG</strong><br />

Section 34b of the German Securities Trading Act in combination with the FinAnV requires an enterprise preparing a<br />

securities analysis to point out possible conflicts of interest with respect to the company that is the subject of the analysis.<br />

A conflict of interest is assumed, in particular, when the enterprise preparing the analysis …<br />

-1- … or companies affiliated with this enterprise holds 5% or more of the share capital of the analysed company<br />

-2-<br />

-3-<br />

-4-<br />

… or companies affiliated with this enterprise was a member in a consortium which acquired the shares of the<br />

analysed company within the last twelve months<br />

… or companies affiliated with this enterprise manages the securities of the analysed company on the basis of<br />

an existing contract<br />

… or companies affiliated with this enterprise over the previous 12 months has been providing investment<br />

banking services for the analysed company for which a compensation has been or will be paid<br />

-5- … effected an agreement with the analysed company for the preparation of the financial analysis<br />

-6- … or companies affiliated with this enterprise regularly trade in shares or derivatives of the analysed company<br />

-7-<br />

… or the analyst responsible for this company has other important financial interests in relation to the analysed<br />

company such as e.g. the performance of mandates for the analysed company<br />

Company Disclosure Link to the historical price targets and rating changes (last 12 months)<br />

<strong>Muehlhan</strong> <strong>AG</strong> 5, 6 http://www.mmwarburg.com/disclaimer/disclaimer_en/DE000A0KD0F7.htm<br />

C O M M E N T Published 31.07.2012 10


<strong>Muehlhan</strong> <strong>AG</strong><br />

INVESTMENT RECOMMENDATION<br />

Investment recommendation: expected direction of the share price development of the financial instrument up to the given price target<br />

in the opinion of the analyst who covers this financial instrument.<br />

-B- <strong>Buy</strong>: The price of the analysed financial instrument is expected to rise over the next 12 months.<br />

-H- Hold:<br />

The price of the analysed financial instrument is expected to remain mostly flat over the<br />

next 12 months.<br />

-S- Sell: The price of the analysed financial instrument is expected to fall over the next 12 months.<br />

“-“ Rating suspended: The available information currently does not permit an evaluation of the company.<br />

WARBURG RESEARCH GMBH – RESEARCH UNIVERSE BY RATING<br />

Rating Number of stocks % of Universe<br />

<strong>Buy</strong> 116 62<br />

Hold 59 31<br />

Sell 9 5<br />

Rating suspended 4 2<br />

Total 188 100<br />

WARBURG RESEARCH GMBH – ANALYSED RESEARCH UNIVERSE BY RATING …<br />

… Looking only at companies for which a disclosure according to § 34b of the Germany Securities Trading Act and the<br />

FinAnV has to be made.<br />

Rating Number of stocks % of Universe<br />

<strong>Buy</strong> 101 66<br />

Hold 43 28<br />

Sell 7 5<br />

Rating suspended 3 2<br />

Total 154 100<br />

PRICE AND RATING HISTORY MUEHLHAN <strong>AG</strong> AS OF 31.07.2012<br />

C O M M E N T Published 31.07.2012 11<br />

The chart has markings if Warburg Research GmbH<br />

changed its rating in the last 12 months. Every marking<br />

represents the date and closing price on the day of the<br />

rating change.


<strong>Muehlhan</strong> <strong>AG</strong><br />

RESEARCH<br />

Christian Bruns +49 40 309537-253 Henner Rüschmeier +49 40 309537-270<br />

Head of Research cbruns@warburg-research.com Head of Research hrueschmeier@warburg-research.com<br />

Christian Cohrs +49 40 309537-175 Roland Rapelius +49 40 309537-220<br />

Engineering, Logistics ccohrs@warburg-research.com Engineering, Logistics rrapelius@warburg-research.com<br />

Felix Ellmann +49 40 309537-120 Jochen Reichert +49 40 309537-130<br />

Software, IT fellmann@warburg-research.com Telco, Internet, Media jreichert@warburg-research.com<br />

Jörg Philipp Frey +49 40 309537-258 Christopher Rodler +49 40 309537-290<br />

Retail, Consumer Goods jfrey@warburg-research.com Utilities crodler@warburg-research.com<br />

Ulrich Huwald +49 40 309537-255 Malte Schaumann +49 40 309537-170<br />

Health Care, Pharma uhuwald@warburg-research.com Technology mschaumann@warburg-research.com<br />

Thilo Kleibauer +49 40 309537-257 Susanne Schwartze +49 40 309537-155<br />

Retail, Consumer Goods tkleibauer@warburg-research.com Telco, Internet, Media sschwartze@warburg-research.com<br />

Torsten Klingner +49 40 309537-260 Oliver Schwarz +49 40 309537-250<br />

Real Estate tklingner@warburg-research.com Chemicals oschwarz@warburg-research.com<br />

Eggert Kuls +49 40 309537-256 Marc-René Tonn +49 40 309537-259<br />

Engineering ekuls@warburg-research.com Automobiles, Car Suppliers mtonn@warburg-research.com<br />

Frank Laser +49 40 309537-235 Björn Voss +49 40 309537-254<br />

Construction, Industrials flaser@warburg-research.com Car Suppliers, Steel bvoss@warburg-research.com<br />

Andreas Pläsier +49 40 309537-246 Andreas Wolf +49 40 309537-140<br />

Banks, Financial Services aplaesier@warburg-research.com Software, IT awolf@warburg-research.com<br />

Malte Räther +49 40 309537-185 Stephan Wulf +49 40 309537-150<br />

Technology mraether@warburg-research.com Utilities swulf@warburg-research.com<br />

SALES SALES TRADING<br />

Holger Nass +49 40 3282-2669 Oliver Merckel +49 40 3282-2634<br />

Head of Equity Sales hnass@mmwarburg.com Head of Sales Trading omerckel@mmwarburg.com<br />

Klaus Schilling +49 40 3282-2664 Gudrun Bolsen +49 40 3282-2679<br />

Deputy Head of Equity Sales kschilling@mmwarburg.com Sales Trading gbolsen@mmwarburg.com<br />

Christian Alisch +49 40 3282-2667 Bastian Quast +49 40 3282-2701<br />

Scandinavia calisch@mmwarburg.com Sales Trading bquast@mmwarburg.com<br />

Robert Conredel +49 40 3282-2633 Patrick Schepelmann +49 40 3282-2700<br />

Germany rconredel@mmwarburg.com Sales Trading pschepelmann@mmwarburg.com<br />

Matthias Fritsch +49 40 3282-2696 Thekla Struve +49 40 3282-2668<br />

United Kingdom mfritsch@mmwarburg.com Sales Trading tstruve@mmwarburg.com<br />

Michael Kriszun +49 40 3282-2695 Jörg Treptow +49 40 3262-2658<br />

United Kingdom mkriszun@mmwarburg.com Sales Trading jtreptow@mmwarburg.com<br />

Marc Niemann +49 40 3282-2660<br />

Germany mniemann@mmwarburg.com Support<br />

Dirk Rosenfelder +49 40 3282-2692 Katharina Bruns +49 40 3282-2694<br />

Austria, Switzerland drosenfelder@mmwarburg.com Roadshow/Marketing kbruns@mmwarburg.com<br />

Julian Straube +49 40 3282-2666<br />

Germany jstraube@mmwarburg.com<br />

Philipp Stumpfegger +49 40 3282-2635<br />

Australia pstumpfegger@mmwarburg.com<br />

Our research can be found under:<br />

MACRO RESEARCH<br />

C O M M E N T Published 31.07.2012 12<br />

Carsten Klude +49 40 3282-2572<br />

Macro Research cklude@mmwarburg.com<br />

Matthias Thiel +49 40 3282-2401<br />

Macro Research mthiel@mmwarburg.com<br />

Dr. Christian Jasperneite +49 40 3282-2439<br />

Investment Strategy cjasperneite@mmwarburg.com<br />

Warburg Research research.mmwarburg.com/en/index.html Thomson www.thomson.com<br />

Bloomberg MMWA GO Reuters www.knowledge.reuters.com<br />

FactSet www.factset.com Capital IQ www.capitaliq.com<br />

For access please contact:<br />

Andrea Carstensen +49 40 3282-2632 Kerstin Muthig +49 40 3282-2703<br />

Sales Assistance acarstensen@mmwarburg.com Sales Assistance kmuthig@mmwarburg.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!